At a glance
- Originator GlaxoSmithKline
- Class Antiasthmatics; Obesity therapies
- Mechanism of Action Beta 3 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 28 Sep 1998 Discontinued-Preclinical for Diabetes mellitus (Unknown route)
- 15 Jul 1996 Preclinical development for Diabetes mellitus (Unknown route)